Formedix CEO to Speak on Using CDISC to Optimize New and Legacy Study Set-up

Mark Wheeldon of Formedix has been invited to present at the upcoming Association of Clinical Data Management (ACDM) Annual Conference in Reading, UK on March 10, 2014.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
CDISC standards adoption is becoming increasingly more important within the life sciences industry

Burlington, MA (PRWEB) March 05, 2014

Industry expert, Mark Wheeldon has been invited to speak at the ACDM Annual Conference, this year being held in Reading, UK from March 9-11, 2014. The Formedix CEO’s presentation will discuss ‘Using CDISC to optimize set-up of both new and legacy studies’, providing a deeper insight into where Define fits into an end-to-end clinical trial, how it can be used for both new and legacy studies and also how to establish an end-to-end library using CDISC standards.

ACDM aims to lead the development and appreciation of the essential activities of the Clinical Data Management profession. The organization’s intent is ‘to equip (members) to participate more effectively in the mainstream of drug development.’ This year’s conference program focuses on topics like data transparency, dedicated technology and interactive innovation and includes presentations from industry experts discussing ‘The Future of Pharma: evolutionary threats and opportunities’, ‘Data standards and exports: getting to submission faster’, and ‘Applying ingenious thinking to the future of CDM’.

Mark and the Formedix team have been active supporters of the Clinical Data Standards Interchange Consortium (CDISC) since inception and are still amongst the longest standing members. On the subject of CDISC standards, Mark says “CDISC standards adoption is becoming increasingly more important within the life sciences industry which is clear from the announcement by the FDA of its intent to require CDISC standards in the future. I strongly believe that a more efficient end-to-end clinical trial process lies firmly in the successful implementation of data standards and clinical trial automation technologies.”

Next month, Formedix will also be exhibiting at the CDISC Europe Interchange 2014, in Paris, France from April 9-11. Kevin Burges, Formedix Technical Business and Standards Director, will be presenting as part of a full program of distinguished speakers. His presentation will focus on the topic of ‘Breaking free from XPT files with CDISC StudyDataSet-XML’. As one of the founding members of the CDISC XML Technologies Governance team, Kevin is a true industry expert, and the ideal candidate to discuss the advantages of CDISC standards use.

For more information on Formedix clinical trial automation software and consultancy services, contact Formedix.
To view the full program for the ACDM Annual Conference 2014, visit the event website.

About Formedix

Formedix clinical trial automation software and services enable you to remove manual, expensive, inefficient and labor intensive tasks from study set-up, EDC build, validation and submission publication processes.

In fact, across every area of your end-to-end clinical trial, the time and cost savings they deliver speak for themselves and continue to do so time and time again...

Formedix saves 68% in set-up time and 55% in EDC build time. With 70% reuse of your content, resources are cut by 23%. It’s all in the numbers.


Contact

  • Nicola Rogerson
    Formedix
    +44 1413534010
    Email